BSH 2019 | New therapies in AML with Steven Knapper

Steven Knapper

Steven Knapper, DM, FRCPath, MRCP, BMBCh, Cardiff University, Cardiff, Wales, UK, speaks at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK. He gives us an overview of new therapies in acute myeloid leukemia (AML), which has seen an explosion of new agents and approvals.

Share this video